To better help fight the Omicron variant of COVID-19, the U.S. Food and Drug Administration has issued an Emergency Use Authorization for bivalent COVID-19 vaccine for booster doses. This was followed by Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices’ recommendation for use of the Pfizer bivalent booster vaccine for ages … Read more